CoChat
Sign Up
Cited by 142Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsGlycogen Storage Diseases and Myoclonus

Impaired Activation of Glycogen Synthase in People at Increased Risk for Developing NIDDM

Schalin-Jäntti, Camilla, Härkönen, Matti, Groop, Leif C·1992·Diabetes
DOI 10.2337/diab.41.5.598
Open this paper in CoChat — free account

Abstract

To study whether impaired activation of muscle glycogen synthase represents an early defect in the pathogenesis of insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM), we quantitated rates of nonoxidative glucose metabolism and measured activities of glycogen synthase and phosphorylase and concentrations of free glucose and glucose-6-phosphate in muscle biopsies, obtained before and after a euglycemic insulin clamp, in 16 NIDDM patients, 18 first-degree relatives of NIDDM patients, and 16 nondiabetic control subjects. Insulin-stimulated glucose storage (20.1 ± 1.5 and 11.6 ± 1.7 vs. 27.9 ± 1.7 βmol·kg−1 lean body mass [LBM]·min−1 P < 0.01–0.001 [3.6 ± 0.3 and 2.1 ± 0.3 vs. 5.0 ± 0.3 mg·kg−1 LBM·min−1] and glycogen synthase activity, measured at 0.1 mM glucose-6-phosphate concentration (11.3 ± 1.3 and 11.6 ± 1.3 vs. 18.3 ± 2.0 nmol·min−1·mg−1 protein, P < 0.01), were impaired in relatives and diabetic subjects compared with control subjects. Glycogen synthase activity correlated with the rate of glucose storage (r = 0.53, P < 0.001). Glycogen phosphorylase fractional activity did not differ among the groups. Apart from increased intramuscular basal glucose concentrations in NIDDM patients, no consistent differences were observed in free glucose and glucose-6-phosphate concentrations between the groups. We conclude that impaired activation of muscle glycogen synthase by insulin is observed in patients with a genetic risk of developing NIDDM and may represent an early defect in the pathogenesis of NIDDM.

Integrity signals

Registry

Crossref · 10.2337/diab.41.5.598

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is no evidence that an alteration in glycogen phosphorylase plays any role in the abnormality in glycogen formation in type 2 diabetes.

    “Similarly, there is no evidence that an alteration in glycogen phosphorylase plays any role in the abnormality in glycogen formation in type 2 diabetes [228].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [228]

Cites

Still being checked.

Cited by

Sorted by citations

Related

Authors
Schalin-Jäntti, C., Härkönen, M., & Groop, L. C.
Affiliations
  • Department of Medicine, Departments of Biochemistry and Clinical Chemistry, Helsinki University Helsinki, Finland
  • University of Helsinki (FI)
ORCID
Groop, Leif C
Venue
Diabetes
Publisher
American Diabetes Association
Published
1992-05-01
Volume
41
Issue
5
Pages
598-604
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
DOI
10.2337/diab.41.5.598
OpenAlex
W2155875957
Cited by
142
References
0
Citations by year
2025: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 1 · 2015: 2 · 2014: 1 · 2013: 1
FWCI
4.75
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
Keywords
glycogen synthase, insulin resistance, type 2 diabetes, type 2 diabetes risk, first-degree relatives, glycogen phosphorylase, glucose-6-phosphate, hyperinsulinemic-euglycemic clamp, nonoxidative glucose metabolism
MeSH terms
Adult, Biopsy, Diabetes Mellitus, Type 2, Enzyme Activation, Female, Glucose, Glucosephosphates, Phosphorylases, Glycogen Synthase, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Muscles, Risk Factors, Glucose-6-Phosphate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review